Berger M - Search Results

1

[The etiopathogenesis of unipolar depression. Neurobiological and psychosocial factors].

Brakemeier EL, Normann C, Berger M. Brakemeier EL, et al. Among authors: berger m. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2008 Apr;51(4):379-91. doi: 10.1007/s00103-008-0505-x. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2008. PMID: 18357422 Review. German.

2

[Affective disorders. The significance of psychotherapeutic approaches].

Berger M, Brakemeier EL, Klesse C, Schramm E. Berger M, et al. Nervenarzt. 2009 May;80(5):540, 542-4, 546-8 passim. doi: 10.1007/s00115-008-2624-x. Nervenarzt. 2009. PMID: 19404606 Review. German.

3

Steroid-responsive depression.

Normann C, Frase L, Berger M, Nissen C. Normann C, et al. Among authors: berger m. BMJ Case Rep. 2013 Apr 18;2013:bcr2013009101. doi: 10.1136/bcr-2013-009101. BMJ Case Rep. 2013. PMID: 23605832 Free PMC article.

4

[Overcoming treatment resistance in chronic depression : The role of inpatient psychotherapy].

Köhler S, Sterzer P, Normann C, Berger M, Brakemeier EL. Köhler S, et al. Among authors: berger m. Nervenarzt. 2016 Jul;87(7):701-7. doi: 10.1007/s00115-015-0034-4. Nervenarzt. 2016. PMID: 26610341 German.

5

Neuroenhancement: status quo and perspectives.

Normann C, Berger M. Normann C, et al. Among authors: berger m. Eur Arch Psychiatry Clin Neurosci. 2008 Nov;258 Suppl 5:110-4. doi: 10.1007/s00406-008-5022-2. Eur Arch Psychiatry Clin Neurosci. 2008. PMID: 18985306 Review.

6

[Options, limits and ethics of pharmacological neuroenhancement].

Normann C, Boldt J, Maio G, Berger M. Normann C, et al. Among authors: berger m. Nervenarzt. 2010 Jan;81(1):66-74. doi: 10.1007/s00115-009-2858-2. Nervenarzt. 2010. PMID: 19851745 Review. German.

7

Cognitive Behavioral Analysis System of Psychotherapy versus Escitalopram in Chronic Major Depression.

Schramm E, Zobel I, Schoepf D, Fangmeier T, Schnell K, Walter H, Drost S, Schmidt P, Brakemeier EL, Berger M, Normann C. Schramm E, et al. Among authors: berger m. Psychother Psychosom. 2015;84(4):227-40. doi: 10.1159/000381957. Epub 2015 May 23. Psychother Psychosom. 2015. PMID: 26022410 Clinical Trial.

8

[Guideline-adherent psychiatric-psychotherapeutic hospital care: Normative definition of staff required using the example of depression].

Berger M, Wolff J, Normann C, Godemann F, Schramm E, Klimke A, Heinz A, Herpertz SC. Berger M, et al. Nervenarzt. 2015 May;86(5):542-8. doi: 10.1007/s00115-015-4310-0. Nervenarzt. 2015. PMID: 25877043 German.

9

The impact of childhood maltreatment on the differential efficacy of CBASP versus escitalopram in patients with chronic depression: A secondary analysis.

Bausch P, Fangmeier T, Zobel I, Schoepf D, Drost S, Schnell K, Walter H, Berger M, Normann C, Schramm E. Bausch P, et al. Among authors: berger m. Clin Psychol Psychother. 2017 Sep;24(5):1155-1162. doi: 10.1002/cpp.2081. Epub 2017 Mar 21. Clin Psychol Psychother. 2017. PMID: 28326653 Clinical Trial.

10

Psychosis during chronic levodopa therapy triggered by the new antidepressive drug mirtazapine.

Normann C, Hesslinger B, Frauenknecht S, Berger M, Walden J. Normann C, et al. Among authors: berger m. Pharmacopsychiatry. 1997 Nov;30(6):263-5. doi: 10.1055/s-2007-979504. Pharmacopsychiatry. 1997. PMID: 9442549

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,107 results

Search Page

Filters